# CAPRICOR THERAPEUTICS, INC. (CAPR) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from CAPRICOR THERAPEUTICS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CAPR/mda/fy2025/): filed 2026-03-17; accession 0001104659-26-029580 (https://www.sec.gov/Archives/edgar/data/1133869/000110465926029580/capr-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/CAPR/mda/fy2024/): filed 2025-03-26; accession 0001558370-25-003707 (https://www.sec.gov/Archives/edgar/data/1133869/000155837025003707/capr-20241231x10k.htm)
- [FY 2023 MD&A](/company/CAPR/mda/fy2023/): filed 2024-03-11; accession 0001558370-24-002861 (https://www.sec.gov/Archives/edgar/data/1133869/000155837024002861/capr-20231231x10k.htm)
- [FY 2022 MD&A](/company/CAPR/mda/fy2022/): filed 2023-03-17; accession 0001558370-23-004124 (https://www.sec.gov/Archives/edgar/data/1133869/000155837023004124/capr-20221231x10k.htm)
- [FY 2021 MD&A](/company/CAPR/mda/fy2021/): filed 2022-03-11; accession 0001558370-22-003341 (https://www.sec.gov/Archives/edgar/data/1133869/000155837022003341/capr-20211231x10k.htm)

Back to /company/CAPR/